Logo image of CLX

CLOROX COMPANY (CLX) Stock Fundamental Analysis

USA - NYSE:CLX - US1890541097 - Common Stock

105.395 USD
+0.69 (+0.66%)
Last: 11/13/2025, 9:37:04 AM
Fundamental Rating

5

Taking everything into account, CLX scores 5 out of 10 in our fundamental rating. CLX was compared to 12 industry peers in the Household Products industry. There are concerns on the financial health of CLX while its profitability can be described as average. CLX has a decent growth rate and is not valued too expensively. CLX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CLX was profitable.
CLX had a positive operating cash flow in the past year.
CLX had positive earnings in each of the past 5 years.
In the past 5 years CLX always reported a positive cash flow from operatings.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

CLX has a Return On Assets of 14.31%. This is amongst the best in the industry. CLX outperforms 83.33% of its industry peers.
CLX has a better Return On Invested Capital (21.90%) than 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLX is above the industry average of 14.90%.
The 3 year average ROIC (18.59%) for CLX is below the current ROIC(21.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROIC 21.9%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100 200 300 400

1.3 Margins

Looking at the Profit Margin, with a value of 11.68%, CLX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CLX's Profit Margin has declined in the last couple of years.
CLX has a Operating Margin of 15.17%. This is comparable to the rest of the industry: CLX outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of CLX has declined.
Looking at the Gross Margin, with a value of 44.28%, CLX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CLX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLX is creating value.
CLX has less shares outstanding than it did 1 year ago.
CLX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLX has a worse debt to assets ratio.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

CLX has an Altman-Z score of 3.15. This indicates that CLX is financially healthy and has little risk of bankruptcy at the moment.
CLX has a Altman-Z score (3.15) which is in line with its industry peers.
CLX has a debt to FCF ratio of 4.25. This is a neutral value as CLX would need 4.25 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.25, CLX is in line with its industry, outperforming 41.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Altman-Z 3.15
ROIC/WACC2.81
WACC7.8%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CLX has a Current Ratio of 0.76. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
CLX has a worse Current ratio (0.76) than 83.33% of its industry peers.
A Quick Ratio of 0.50 indicates that CLX may have some problems paying its short term obligations.
CLX has a Quick ratio of 0.50. This is amonst the worse of the industry: CLX underperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.5
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

CLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.99%.
CLX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.01% yearly.
CLX shows a decrease in Revenue. In the last year, the revenue decreased by -9.35%.
The Revenue has been growing slightly by 1.11% on average over the past years.
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%

3.2 Future

CLX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.83% yearly.
CLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.40% yearly.
EPS Next Y-22.2%
EPS Next 2Y-5.8%
EPS Next 3Y-1.93%
EPS Next 5Y2.83%
Revenue Next Year-7.81%
Revenue Next 2Y-1.89%
Revenue Next 3Y-0.24%
Revenue Next 5Y1.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

CLX is valuated correctly with a Price/Earnings ratio of 15.68.
CLX's Price/Earnings is on the same level as the industry average.
CLX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.34.
CLX is valuated correctly with a Price/Forward Earnings ratio of 15.37.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLX is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CLX to the average of the S&P500 Index (34.43), we can say CLX is valued rather cheaply.
Industry RankSector Rank
PE 15.68
Fwd PE 15.37
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLX is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as CLX.
Industry RankSector Rank
P/FCF 20.18
EV/EBITDA 12.07
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The decent profitability rating of CLX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)15.48
EPS Next 2Y-5.8%
EPS Next 3Y-1.93%

7

5. Dividend

5.1 Amount

CLX has a Yearly Dividend Yield of 4.72%, which is a nice return.
CLX's Dividend Yield is rather good when compared to the industry average which is at 3.21. CLX pays more dividend than 83.33% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, CLX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.72%

5.2 History

The dividend of CLX has a limited annual growth rate of 2.88%.
CLX has paid a dividend for at least 10 years, which is a reliable track record.
CLX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

76.11% of the earnings are spent on dividend by CLX. This is not a sustainable payout ratio.
CLX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP76.11%
EPS Next 2Y-5.8%
EPS Next 3Y-1.93%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

CLOROX COMPANY

NYSE:CLX (11/13/2025, 9:37:04 AM)

105.395

+0.69 (+0.66%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners91%
Inst Owner Change-1.53%
Ins Owners0.24%
Ins Owner Change13.55%
Market Cap12.83B
Revenue(TTM)6.77B
Net Income(TTM)791.00M
Analysts54.81
Price Target136.17 (29.2%)
Short Float %5.33%
Short Ratio3.64
Dividend
Industry RankSector Rank
Dividend Yield 4.72%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP76.11%
Div Incr Years34
Div Non Decr Years34
Ex-Date10-22 2025-10-22 (1.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.83%
Min EPS beat(2)6.97%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)9.13%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)52.89%
EPS beat(16)13
Avg EPS beat(16)41.78%
Revenue beat(2)2
Avg Revenue beat(2)1.32%
Min Revenue beat(2)1.06%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)2.62%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)9
Avg Revenue beat(12)2.28%
Revenue beat(16)11
Avg Revenue beat(16)1.58%
PT rev (1m)-2.93%
PT rev (3m)-3.72%
EPS NQ rev (1m)-9.69%
EPS NQ rev (3m)-30.76%
EPS NY rev (1m)-2.25%
EPS NY rev (3m)-10.86%
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)-4.52%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-5.27%
Valuation
Industry RankSector Rank
PE 15.68
Fwd PE 15.37
P/S 1.9
P/FCF 20.18
P/OCF 15.05
P/B N/A
P/tB N/A
EV/EBITDA 12.07
EPS(TTM)6.72
EY6.38%
EPS(NY)6.86
Fwd EY6.51%
FCF(TTM)5.22
FCFY4.96%
OCF(TTM)7.01
OCFY6.65%
SpS55.6
BVpS-0.18
TBVpS-14.86
PEG (NY)N/A
PEG (5Y)15.48
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROCE 31.18%
ROIC 21.9%
ROICexc 22.99%
ROICexgc 49.37%
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
FCFM 9.39%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Debt/EBITDA 2.17
Cap/Depr 98.19%
Cap/Sales 3.2%
Interest Coverage 250
Cash Conversion 68.35%
Profit Quality 80.4%
Current Ratio 0.76
Quick Ratio 0.5
Altman-Z 3.15
F-Score6
WACC7.8%
ROIC/WACC2.81
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
EPS Next Y-22.2%
EPS Next 2Y-5.8%
EPS Next 3Y-1.93%
EPS Next 5Y2.83%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%
Revenue Next Year-7.81%
Revenue Next 2Y-1.89%
Revenue Next 3Y-0.24%
Revenue Next 5Y1.4%
EBIT growth 1Y-13.41%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year6.95%
EBIT Next 3Y6.71%
EBIT Next 5Y6.75%
FCF growth 1Y-19.9%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y-14.7%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CLX FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 5 / 10 to CLX.


What is the valuation status of CLOROX COMPANY (CLX) stock?

ChartMill assigns a valuation rating of 4 / 10 to CLOROX COMPANY (CLX). This can be considered as Fairly Valued.


What is the profitability of CLX stock?

CLOROX COMPANY (CLX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CLOROX COMPANY?

The Earnings per Share (EPS) of CLOROX COMPANY (CLX) is expected to decline by -22.2% in the next year.


Is the dividend of CLOROX COMPANY sustainable?

The dividend rating of CLOROX COMPANY (CLX) is 7 / 10 and the dividend payout ratio is 76.11%.